bioAffinity Technologies (BIAFW) Equity Ratio (2021 - 2026)

bioAffinity Technologies (BIAFW) has 6 years of Equity Ratio data on file, last reported at 0.46 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.46, up 77.6% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.46 (up 77.6% YoY), and the FY2025 annual result was 0.66, up 66.21% from the prior year.
• Equity Ratio fell to 0.46 in Q1 2026 per BIAFW's latest filing, from 0.66 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.92 in Q1 2023 and troughed at 0.45 in Q2 2025.
• A 5-year average of 0.58 and a median of 0.65 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2025: Equity Ratio soared 108.34% in 2022, then tumbled 187.17% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.91 in 2022, then plunged by 34.86% to 0.59 in 2023, then tumbled by 32.36% to 0.4 in 2024, then jumped by 66.21% to 0.66 in 2025, then sank by 30.6% to 0.46 in 2026.
• Business Quant data shows BIAFW's Equity Ratio at 0.46 in Q1 2026, 0.66 in Q4 2025, and 0.77 in Q3 2025.